By Dorothy Atkins ( June 28, 2018, 4:14 PM EDT) -- The Federal Circuit on Thursday affirmed a Delaware federal court ruling that rejected arguments made by generic-drug maker Lannett Co. Inc. that two AstraZeneca AB nasal spray patents covering Impax's migraine drug Zomig are invalid, finding that it wasn't obvious to make the drug into a nasal spray....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.